ADAM17 and Alzheimer disease: This is of particular interest because loss-of-function mutations in the sTREM2 sheddace TACE/ADAM17 are linked to AD13, and other substrates for this enzyme are commonly implicated in the assessment of AD-related inflammatory changes8,14–18.